Mutations Changing the Kinetics of Class II MHC Peptide Exchange

Slides:



Advertisements
Similar presentations
Volume 13, Pages (November 2016)
Advertisements

Volume 14, Issue 8, Pages (August 2007)
Volume 124, Issue 6, Pages (March 2006)
The Structure of a Bcl-xL/Bim Fragment Complex
Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
Structural Basis of Interdomain Communication in the Hsc70 Chaperone
Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface by Hironao Wakabayashi, Fatbardha Varfaj,
Affinity Dependence of the B Cell Response to Antigen: A Threshold, a Ceiling, and the Importance of Off-Rate  Facundo D Batista, Michael S Neuberger 
Volume 15, Issue 5, Pages (September 2004)
Volume 11, Issue 10, Pages (October 2004)
Volume 13, Issue 4, Pages (October 2000)
Volume 14, Issue 3, Pages (March 2001)
Volume 158, Issue 1, Pages (July 2014)
The structure of the GPIb–filamin A complex
Volume 124, Issue 1, Pages (January 2006)
Huifang Huang, Stephen C Harrison, Gregory L Verdine 
Volume 8, Issue 6, Pages (June 1998)
Volume 1, Issue 5, Pages (June 2002)
Volume 21, Issue 9, Pages (September 2013)
Volume 115, Issue 2, Pages (October 2003)
Structural Basis for the Specific Recognition of Methylated Histone H3 Lysine 4 by the WD-40 Protein WDR5  Zhifu Han, Lan Guo, Huayi Wang, Yue Shen, Xing.
The Structure of a Bcl-xL/Bim Fragment Complex
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
Volume 13, Issue 5, Pages (November 2000)
Einav Gross, David B Kastner, Chris A Kaiser, Deborah Fass  Cell 
Volume 109, Issue 4, Pages (May 2002)
Erik Procko, Ian Ferrin-O'Connell, Sze-Ling Ng, Rachelle Gaudet 
Myosin VI Undergoes Cargo-Mediated Dimerization
Volume 10, Issue 2, Pages (February 1999)
Volume 35, Issue 1, Pages (July 2011)
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Volume 1, Issue 6, Pages (December 1996)
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
De Novo Design of Foldable Proteins with Smooth Folding Funnel
Volume 11, Issue 1, Pages (July 1999)
Volume 89, Issue 5, Pages (May 1997)
Volume 24, Issue 10, Pages (October 2016)
Yanhui Xu, Yu Chen, Ping Zhang, Philip D. Jeffrey, Yigong Shi 
Leonardus M.I. Koharudin, Angela M. Gronenborn  Structure 
Volume 92, Issue 6, Pages (March 2007)
Volume 18, Issue 8, Pages (August 2010)
Andrew H. Huber, W.James Nelson, William I. Weis  Cell 
Crystal Structure of the TAO2 Kinase Domain
Elizabeth J. Little, Andrea C. Babic, Nancy C. Horton  Structure 
Structure of the Catalytic Domain of Human DOT1L, a Non-SET Domain Nucleosomal Histone Methyltransferase  Jinrong Min, Qin Feng, Zhizhong Li, Yi Zhang,
Volume 56, Issue 6, Pages (December 2007)
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Volume 143, Issue 2, Pages (October 2010)
Structural Basis for Specific Recognition of Reelin by Its Receptors
Calnexin Discriminates between Protein Conformational States and Functions as a Molecular Chaperone In Vitro  Yoshito Ihara, Myrna F Cohen-Doyle, Yoshiro.
Structural Basis of Caspase-7 Inhibition by XIAP
Qun Liu, Qingqiu Huang, Xin Gen Lei, Quan Hao  Structure 
Volume 9, Issue 12, Pages (December 2001)
Formation of a Highly Peptide-Receptive State of Class II MHC
Volume 6, Issue 4, Pages (October 2000)
Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation
Volume 11, Issue 4, Pages (February 2001)
Volume 9, Issue 5, Pages (May 2001)
The Inhibitory Receptor LIR-1 Uses a Common Binding Interaction to Recognize Class I MHC Molecules and the Viral Homolog UL18  Tara L Chapman, Astrid.
Volume 9, Issue 3, Pages (March 2001)
Volume 9, Issue 12, Pages (December 2001)
Jianchao Li, Haiyang Liu, Manmeet H. Raval, Jun Wan, Christopher M
Volume 9, Issue 8, Pages (August 2002)
The Structure of the GGA1-GAT Domain Reveals the Molecular Basis for ARF Binding and Membrane Association of GGAs  Brett M. Collins, Peter J. Watson,
Interaction of the NK Cell Inhibitory Receptor Ly49A with H-2Dd
PDZ Tandem of Human Syntenin
Structure of GABARAP in Two Conformations
How the T Cell Repertoire Becomes Peptide and MHC Specific
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Volume 15, Issue 6, Pages (September 2004)
Presentation transcript:

Mutations Changing the Kinetics of Class II MHC Peptide Exchange Nancy Wilson, Daved Fremont, Philippa Marrack, John Kappler  Immunity  Volume 14, Issue 5, Pages 513-522 (May 2001) DOI: 10.1016/S1074-7613(01)00140-6

Figure 1 Similar Electrophoretic Properties of Native wt and mut IEk Molecules Aliquots (1 μg) of wt or mut IEk containing covalently bound pMCC, pHSP, or pHB were analyzed by native PAGE using a 10%–15% gradient acrylamide gel with the pHast system. Gels were stained with Coomassie Blue Immunity 2001 14, 513-522DOI: (10.1016/S1074-7613(01)00140-6)

Figure 2 Antigenic Similarities of wt and mut IEk Molecules The anti-IEk mAbs shown were immobilized in the flow cells of a BIAcore CM5 Biasensor chip. Aliquots (30 μl, 1 μM) of mut (open bars) or wt (filled bars) IEk containing covalently bound pMCC, pHSP, or pHB were injected at a flow rate of 15 μl/min and the binding kinetics recorded. Association rates (liters/mole·s) and dissociation rates (1/s) were estimated using standard BIAcore software assuming first order kinetics. These rates were used to calculate the association constants (liters/mole) Immunity 2001 14, 513-522DOI: (10.1016/S1074-7613(01)00140-6)

Figure 3 mut IEk Is Less Stable Than wt IEk under Denaturing Conditions (A) Aliquots of mutant (open squares) or wt (closed circles) IEk with no covalently bound peptide were loaded in vitro with pMCC, pHSP, or pHB. The preparations were then incubated at pH 5.5 ( ), pH 5.0 ( ), or pH 4.5 ( ) in the presence of 640 molar excess of pMCC. Aliquots were removed at various times and diluted in buffer at pH 7.0. Capture ELISA was used to determine the loss of associated IEk α and β chains. The anti-Eβk mAb, Y17, was used for capture and the anti-Eα mAb, 14-4-4, was used for detection. Results are shown as the percent of assembled IEk remaining versus time. (B) The CD spectra of wt ( ) or mutant ( ) IEk containing covalently bound pMCC (right panels) or pHB (left panels) were measured at pH 7.4 at various temperatures. Mean residue ellipticity is shown at two wavelengths: far UV (200 nm) (upper panels) and near UV (293 nm) (lower panels). Transition temperatures (Tm) were estimated from polynomial curves fit to the data. They were defined as the temperature at which the CD signal was reduced by one-half of its maximum range for either molecule Immunity 2001 14, 513-522DOI: (10.1016/S1074-7613(01)00140-6)

Figure 4 mut IEk Exchanges Peptide Very Rapidly Compared to wt IEk (A) On rate: mut (○) and wt (•) IEk-pHSP were digested with thrombin to cleave the covalent linker between the peptide and MHC β chain. Aliquots were incubated with 640-fold molar excess of biotinylated forms of pMCC, pHSP, or pHB at pH 7.5 ( ), pH 5.5 ( ), or pH 5.0 ( ). At various times, aliquots were removed and diluted 1:200 in 2% fetal calf serum in Tris buffered saline at pH 7.5. Biotinylated peptide associated with IEk was determined in an ELISA capturing with the anti-Eβk mAb, Y-17, and detecting the biotinylated peptide directly with AP-coupled extravidin. The largest amount of bio-peptide bound in any sample was bio-pHB binding to mut IEk at 60 min at pH 5.0. This value was arbitrarily set to 100%. The results for all the samples relative to this one are plotted versus the time in minutes. (B) Off rate: mut (○) or wt (•) IEk produced without any covalent peptide were preloaded with biotinylated versions of pMCC, pHSP, and pHB. Samples of each were incubated at pH 7.5 ( ), pH 5.5 ( ), or pH 5.0 ( ) in the presence of 640-fold molar excess of pMCC. Aliquots were taken at several time points and assayed for IEk bound biotinylated peptide as in (A). Results are plotted as the % of IEk associated biotinylated peptide remaining versus time in minutes Immunity 2001 14, 513-522DOI: (10.1016/S1074-7613(01)00140-6)

Figure 5 Comparison of the Structures of mut and wt Iek (A) Ribbon structures are shown of the α1, β1, and peptide portions of mutant (cyan, red, and magenta) and wt (yellow, blue, and green) aligned similarly. The structures are a cross-eyed stereo pair such that when viewed in stereo the two structures superimpose. Figure created with Molscript (Kraulis, 1991). (B) Two different views of electron density (σ = 1.0) surrounding key amino acids in the P6 pocket of the mut IEk. The atom coloring scheme for mut IEk is: C, yellow; protein O, red; N, blue; S, green; and water O, cyan. Figure created with O (Jones and Kjeldgaard, 1997). (C) Some details of the IEk P6 binding pocket with the mut and wt molecules superimposed. The atom coloring scheme for mut IEk is C, white; protein O, red; N, blue; S, yellow; and water O, cyan. The wt IEk is colored green throughout. The figure is a cross-eyed stereo pair created with Swiss PDBViewer (Guex and Peitsch, 1997). (D and E) Some details of the predicted hydrogen bonding networks in the vicinity of the P6 peptide binding pocket are shown for the wt (D) and mut (E) IEk molecules. The atom coloring scheme for mut IEk is as in (C). Potential H-bonds were detected with the aid of Swiss PDBViewer and some are shown as dotted green lines. Figures are cross-eyed stereo pairs also created with Swiss PDBViewer Immunity 2001 14, 513-522DOI: (10.1016/S1074-7613(01)00140-6)

Figure 6 Hypothetical Scheme of wt and mut IEk Peptide Exchange See text for details Immunity 2001 14, 513-522DOI: (10.1016/S1074-7613(01)00140-6)